DiaMedica Therapeutics (DMAC) Other Non-Current Assets (2017 - 2024)
DiaMedica Therapeutics' (DMAC) quarterly Other Non-Current Assets came in at $1.3 million in Q4 2024, little changed quarter-over-quarter from $1.3 million in Q3 2024.
DiaMedica Therapeutics (DMAC) Other Non-Current Assets (2017 - 2024) Analysis & Trends
DiaMedica Therapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.3 million for Q4 2024.
- On a quarterly basis, Other Non-Current Assets changed N/A year-over-year to $1.3 million in Q4 2024; TTM through Dec 2024 was $1.3 million, a N/A change from a year earlier, with the FY2024 full-year figure at $1.3 million, changed N/A from the prior year.
- Other Non-Current Assets held at $1.3 million in Q4 2024 per DMAC's latest filing, from $1.3 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.3 million in Q1 2024 and bottomed at $1.3 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | DiaMedica Therapeutics | 366.87 Mn | 366.87 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.31 Mn |
| Sep 30, 2024 | 1.31 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.31 Mn |
| Jun 30, 2019 | 271,000.00 |
| Mar 31, 2019 | 271,000.00 |
| Dec 31, 2018 | 271,000.00 |
| Dec 31, 2017 | 271,000.00 |